[Clinical and laboratory studies in patients with pulmonary tuberculosis treated with pyrazinamide]. / Klinicheskie i laboratornye issledovaniia u bol'nykh tuberkulezom legkikh, lechennykh pirazinamidom.
Probl Tuberk
; (11): 25-8, 1990.
Article
en Ru
| MEDLINE
| ID: mdl-2290809
ABSTRACT
Different combinations of tuberculostatic drugs containing pyrazinamide were prescribed to 144 patients with pulmonary tuberculosis. In 3 months of treatment, bacterial excretion was observed in 89.7% of newly diagnosed patients and in 59% of cases with chronic forms of pulmonary tuberculosis. Side effects due to pyrazinamide were registered in 16.8% of the patients. In 2-3 months of therapy there were no differences traced in the condition of the liver, lipoid peroxidation or antioxidative activity as well as in a number of immunologic indices both in subjects receiving different combinations of antituberculous drugs, containing pyrazinamide, and in the control group of patients untreated with the drug.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Pirazinamida
/
Tuberculosis Pulmonar
/
Antituberculosos
Límite:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
Ru
Revista:
Probl Tuberk
Año:
1990
Tipo del documento:
Article